Sunzen Biotech Bhd (0148) - Total Liabilities

Latest as of March 2024: RM18.73 Million MYR ≈ $4.70 Million USD

Based on the latest financial reports, Sunzen Biotech Bhd (0148) has total liabilities worth RM18.73 Million MYR (≈ $4.70 Million USD) as of March 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Sunzen Biotech Bhd equity growth rate to track the company's year-over-year net asset growth rate.

Sunzen Biotech Bhd - Total Liabilities Trend (2016–2023)

This chart illustrates how Sunzen Biotech Bhd's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Sunzen Biotech Bhd generate to measure how efficiently the company converts operating cash flow to free cash.

Sunzen Biotech Bhd Competitors by Total Liabilities

The table below lists competitors of Sunzen Biotech Bhd ranked by their total liabilities.

Company	Country	Total Liabilities
Li Cheng Enterprise Co Ltd TW:4426	Taiwan	NT$2.34 Billion
Kristal Kola ve Mesrubat Sanayi Ticaret AS IS:KRSTL	Turkey	TL1.07 Billion
eXoZymes, Inc. NASDAQ:EXOZ	USA	$2.49 Million
Viscom AG XETRA:V6C	Germany	€45.49 Million
Walkabout Resources Ltd AU:WKT	Australia	AU$36.64 Million
Sinher Technology Inc TW:4999	Taiwan	NT$609.18 Million
Beijing JIAYU Door Window Curtain SHE:300117	China	CN¥2.84 Billion
PEH Wertpapier AG F:PEH	Germany	€28.76 Million

Liability Composition Analysis (2016–2023)

This chart breaks down Sunzen Biotech Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 0148 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.71	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.14	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.12	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sunzen Biotech Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sunzen Biotech Bhd (2016–2023)

The table below shows the annual total liabilities of Sunzen Biotech Bhd from 2016 to 2023.

Year	Total Liabilities	Change
2023-12-31	RM20.51 Million ≈ $5.15 Million	-29.46%
2022-12-31	RM29.08 Million ≈ $7.30 Million	-5.01%
2021-12-31	RM30.61 Million ≈ $7.69 Million	-14.34%
2020-12-31	RM35.73 Million ≈ $8.97 Million	-3.32%
2019-12-31	RM36.96 Million ≈ $9.28 Million	-9.05%
2018-12-31	RM40.63 Million ≈ $10.20 Million	+106.30%
2017-12-31	RM19.70 Million ≈ $4.95 Million	+119.33%
2016-12-31	RM8.98 Million ≈ $2.25 Million	--

About Sunzen Biotech Bhd

KLSE:0148 Malaysia Packaged Foods

Market Cap

$45.14 Million

RM179.78 Million MYR

Market Cap Rank

#22268 Global

#498 in Malaysia

Share Price

RM0.23

Change (1 day)

+0.00%

52-Week Range

RM0.23 - RM0.30

All Time High

RM0.44